Skip to main content
Download PDF

Correction: Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial

BMC Infectious Diseases volume 25, Article number: 473 (2025) Cite this article

The Original Article was published on 21 March 2025

Correction: BMC Infect Dis 25, 392 (2025)

https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12879-025-10747-3

Following publication of the original article [1], we were notified that the list of beta-lactam antibiotics was incorrectly written in the Methods section of the Abstract as follows: cefuroxime, ceftazidime, ceftriaxone, cefotaxime, amoxicillin, amoxicillin/clavulanic acid, flucloxacillin, meropenem, and piperacillin/clavulanic acid.

The correct list should be: cefuroxime, ceftazidime, ceftriaxone, cefotaxime, amoxicillin, amoxicillin/clavulanic acid, flucloxacillin, meropenem, and piperacillin/tazobactam.

The original article has been corrected.

Reference

  1. Horstink, et al. Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial. BMC Infect Dis. 2025;25:392. https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12879-025-10747-3.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Intensive Care, Maasstad Hospital, Rotterdam, The Netherlands

    M. M. B. Horstink & C. A. den Uil

  2. Rotterdam Clinical Pharmacometrics Group, Erasmus MC, Rotterdam, The Netherlands

    M. M. B. Horstink, D. R. Geel, A. Abdulla & B. C. P. Koch

  3. Department of Hospital Pharmacy, Erasmus MC, Rotterdam, the Netherlands

    D. R. Geel, A. Abdulla, W. J. R. Rietdijk & B. C. P. Koch

  4. Department of Intensive Care, Albert Schweitzer Hospital, Dordrecht, The Netherlands

    P. E. Deetman

  5. Department of Intensive Care, OLVG, Amsterdam, The Netherlands

    H. Endeman

  6. Department of Intensive Care, Erasmus MC, Rotterdam, The Netherlands

    H. Endeman

  7. Department of Clinical Pharmacology & Toxicology Maasstadlab, Maasstad Hospital, Rotterdam, The Netherlands

    T. M. Bosch

  8. Department of Hospital Pharmacy, Maasstad Hospital, Rotterdam, The Netherlands

    T. M. Bosch

  9. School of Health Policy & Management, Erasmus University, Erasmus Centre for Health Economics Rotterdam, Rotterdam, The Netherlands

    F. W. Thielen

  10. Department of Intensive Care, Isala Hospital, Zwolle, The Netherlands

    J. J. Haringman

  11. Department of Intensive Care Haaglanden Medical Center, The Hague, The Netherlands

    P. van Vliet

  12. Department of Intensive Care, Amphia, Breda, The Netherlands

    T. A. Rijpstra

  13. Department of Intensive Care, Frisius MC, Leeuwarden, The Netherlands

    C. Bethlehem

  14. Department of Intensive Care, Medisch Spectrum Twente, Enschede, The Netherlands

    A. Beishuizen

  15. Department of Medical Microbiology, Haaglanden Medical Center, The Hague, The Netherlands

    A. E. Muller

Authors
  1. M. M. B. Horstink
    View author publications

    You can also search for this author inPubMed Google Scholar

  2. D. R. Geel
    View author publications

    You can also search for this author inPubMed Google Scholar

  3. C. A. den Uil
    View author publications

    You can also search for this author inPubMed Google Scholar

  4. P. E. Deetman
    View author publications

    You can also search for this author inPubMed Google Scholar

  5. H. Endeman
    View author publications

    You can also search for this author inPubMed Google Scholar

  6. A. Abdulla
    View author publications

    You can also search for this author inPubMed Google Scholar

  7. T. M. Bosch
    View author publications

    You can also search for this author inPubMed Google Scholar

  8. W. J. R. Rietdijk
    View author publications

    You can also search for this author inPubMed Google Scholar

  9. F. W. Thielen
    View author publications

    You can also search for this author inPubMed Google Scholar

  10. J. J. Haringman
    View author publications

    You can also search for this author inPubMed Google Scholar

  11. P. van Vliet
    View author publications

    You can also search for this author inPubMed Google Scholar

  12. T. A. Rijpstra
    View author publications

    You can also search for this author inPubMed Google Scholar

  13. C. Bethlehem
    View author publications

    You can also search for this author inPubMed Google Scholar

  14. A. Beishuizen
    View author publications

    You can also search for this author inPubMed Google Scholar

  15. A. E. Muller
    View author publications

    You can also search for this author inPubMed Google Scholar

  16. B. C. P. Koch
    View author publications

    You can also search for this author inPubMed Google Scholar

Consortia

The BULLSEYE investigators

Corresponding author

Correspondence to M. M. B. Horstink.

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Horstink, M.M.B., Geel, D.R., Uil, C.A.d. et al. Correction: Standard versus double dosing of beta-lactam antibiotics in critically ill patients with sepsis: The BULLSEYE study protocol for a multicenter randomized controlled trial. BMC Infect Dis 25, 473 (2025). https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12879-025-10877-8

Download citation

  • Published:

  • DOI: https://doiorg.publicaciones.saludcastillayleon.es/10.1186/s12879-025-10877-8

BMC Infectious Diseases

ISSN: 1471-2334

Contact us